Skip to main navigation
Skip to search
Skip to main content
Oregon Health & Science University Home
Search content at Oregon Health & Science University
Home
Profiles
Research units
Core Facilities
Publications
Hypertriglyceridemia: Pathophysiology, Diagnosis, and Treatment
P. Barton Duell
Knight Cardiovascular Institute
Research output
:
Contribution to journal
›
Article
›
peer-review
4
Link opens in a new tab
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Hypertriglyceridemia: Pathophysiology, Diagnosis, and Treatment'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Hypertriglyceridemia
100%
Quantitative Measurement
20%
Metabolic Abnormalities
20%
Weight Loss
20%
Chylomicrons
20%
Triglyceride-rich Lipoproteins
20%
Low-density Lipoprotein
20%
Family History
20%
Initial Treatment
20%
Overproduction
20%
Triglyceride Level
20%
Most Common Form
20%
Lipoprotein Levels
20%
Lipid Levels
20%
Life-threatening Complications
20%
Drug Treatment
20%
Pancreatitis
20%
Smoking Cessation
20%
Metabolic Disorders
20%
Lipid-lowering Medications
20%
Dietary Modification
20%
Hygienic Measures
20%
Intermediate-density Lipoprotein
20%
Secondary Causes
20%
Overnight Fasting
20%
Detailed Assessment
20%
Pharmacology, Toxicology and Pharmaceutical Science
Pathophysiology
100%
Hypertriglyceridemia
100%
Lipoprotein
50%
Triacylglycerol
50%
Lipid
50%
Hyperlipidemia
25%
Pharmacotherapy
25%
Very Low Density Lipoprotein
25%
Atherosclerosis
25%
Chylomicron
25%
Pancreatitis
25%
Metabolic Disorder
25%
Intermediate Density Lipoprotein
25%
Biochemistry, Genetics and Molecular Biology
Hypertriglyceridemia
100%
Lipid
50%
Chylomicron
25%
Lipoprotein
25%
Hyperlipidemia
25%
Very Low-Density Lipoprotein
25%
Quantitative Technique
25%
Triacylglycerol Level
25%
Metabolic Disorder
25%
Smoking Cessation
25%
Triglyceride-Rich Lipoprotein
25%
Blood Plasma
25%
Drug Therapy
25%
Intermediate-Density Lipoprotein
25%